News

Lipacreon is indicated as a treatment for pancreatic exocrine insufficiency (PEI) due to chronic pancreatitis, pancreatectomy, cystic fibrosis and other conditions. Lipacreon contains pancreatic enzymes such as amylase,

Baxter‘s net income was $570m for the first quarter 2011, or $0.98 per diluted share, compared to net income of $63m, or $0.11 per diluted share, for the

The combination vaccine will help protect from six infectious diseases including diphtheria, tetanus, whooping cough (Bordetella pertussis), polio (poliovirus types 1, 2, and 3), invasive disease caused by

The tie up allows GTG to utilize some of its intellectual property and expertise for the development of specific and novel genetic oncology profiling systems to target chemotherapy

The partnership is intended to leverage both companies’ strengths, matching Pfizer‘s global capabilities in developing medicines with Shanghai Pharmaceutical’s capabilities and reach in the China market. The companies

AIC246 is currently is in Phase IIb trial. AiCuris CEO Rubsamen-Schaeff said the orphan drug status will also support the company in the development of AIC246 as it

Gilead‘s net income was $651.14m for the first quarter 2011, or $0.08 per diluted share, compared to net income of $854.9m, or $0.92 per diluted share, for the

Labeling and marketing materials for the affected products claim that they can prevent infection from other disease-causing agents. In addition, the labeling of some of the firms hand

Wellmune WGP is a product of the US biotechnology company Biothera. Hormel Health Labs said the products, available in Lemonade, Pomegranate-Cherry and Raspberry-Green Tea flavors, provide an immune